N@N

Simon Flannery Initiated (VTYX) at Buy and Held Target at $45 on, Nov 17th, 2022

Simon Flannery of Morgan Stanley, Initiated "Ventyx Biosciences, Inc." (VTYX) at Buy and Held Target at $45 on, Nov 17th, 2022.

Simon has made no other calls on VTYX in the last 4 months.

There are 5 other peers that have a rating on VTYX. Out of the 5 peers that are also analyzing VTYX, 0 agree with Simon's Rating of Hold.

These are the ratings of the 5 analyists that currently disagree with Simon

---

• Alex Thompson of "Stifel" Maintained at Strong Buy with Increased Target to $53 on, Friday, September 16th, 2022
• Emily Bodnar of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $50 on, Tuesday, September 13th, 2022
• Jeff Jones of "Oppenheimer" Maintained at Buy with Increased Target to $65 on, Monday, September 12th, 2022
• Edward Nash of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $35 on, Wednesday, August 17th, 2022
• Tiago Fauth of "Credit Suisse" Maintained at Buy with Increased Target to $63 on, Tuesday, August 16th, 2022

Contributing Sources

---